<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="21524">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01685112</url>
  </required_header>
  <id_info>
    <org_study_id>201207079RIC</org_study_id>
    <nct_id>NCT01685112</nct_id>
  </id_info>
  <brief_title>Comparison of ECMO Use and Conventional Treatment in Adults With Septic Shock</brief_title>
  <official_title>Comparison of ECMO Use and Conventional Treatment in Adults With Septic Shock</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <authority>Taiwan: Department of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although few cases reported successful treatment of septic shock using extracorporeal
      membrane oxygenation (ECMO) in adults, no studies compared ECMO to conventional treatment
      (without ECMO) as treatment for adults with septic shock. Since it is difficult to conduct a
      randomized study to allocate patients in such critical condition, we aimed to conduct a
      retrospective observational study using propensity score matched analysis to compare the
      survival of adults with septic shock treated by ECMO or conventional treatment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">August 2013</completion_date>
  <primary_completion_date type="Anticipated">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Retrospective</study_design>
  <primary_outcome>
    <measure>In hospital mortality</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>inhospital mortality as primary outcome, mean length of hospital stay around 30 days</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>Conventional Group</arm_group_label>
    <description>Patients who developed refractory shock, but didn't received ECMO as salvage treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ECMO group</arm_group_label>
    <description>Patient who have septic shock, and progreseed to have ECMO as salvage therapy</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adults patient who admitted to ICU and had severe sepsis and progressed to septic shock
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt;20

          -  admitted at ICU

          -  septic shock

        Exclusion Criteria:

          -  nil
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>YuChung Chuang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>YuChung Chuang, MD</last_name>
    <phone>886-972652532</phone>
    <email>weischuang@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>YuChung Chuang, MD</last_name>
      <phone>886-972652532</phone>
      <email>weischuang@gmail.com</email>
    </contact>
    <investigator>
      <last_name>YuChung Chuang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <lastchanged_date>October 10, 2012</lastchanged_date>
  <firstreceived_date>September 11, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>adults</keyword>
  <keyword>ECMO</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
